SIGLEC2; BL-CAM; B-cell receptor CD22; B-lymphocyte cell adhesion molecule; T-cell surface antigen Leu-14
CD314; KLR-K1; KLR; NKG2-D; NKG2-D Type II Integral Membrane Protein; NK cell receptor D; NKG2-D-activating NK receptor
EB1; Adenomatous Polyposis Coli-Binding protein; APC-binding protein EB1; End-binding protein 1
CLEC4L; DC-SIGN; CDSIGN; C-Type Lectin Domain Family 4, Member L; Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin
T1; LEU1; Lymphocyte antigen T1/Leu-1
CD25; IL2R-a; IL2-RA; IDDM10; IL2R; TCGFR; p55; TAC antigen
CD69; CLEC2-C; AIM; p60; EA1; MLR-3; Early T-Cell Activation Antigen p60; Early activation antigen CD69; Activation inducer molecule; Leukocyte surface antigen Leu-23
LDH-B; LDH-H; Renal carcinoma antigen NY-REN-46
CMH2; cTnT; TnTc; Cardiomyopathy,Hypertrophic 2; Cardiac muscle troponin T
p32; CD8-A; Leu2; MAL; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2
LFA2; SRBC; T11; T-Cell Surface Antigen T11/Leu-5; LFA-3 Receptor; Lymphocyte Function Associated Antigen 2; Erythrocyte Receptor; Rosette Receptor; Sheep Red Blood Cell Receptor